China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase Ib/II Trial of Lisaftoclax in Combination With PolaRCHP or RCHOP Regimens for Patients With Previously Untreated Diffuse Large B Cell Lymphoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130917
Registration Time: 2026/08/26
Type: Interventional study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339985
Published by HT Digital Content Services with permission from Health Daily Digest....